Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0838 per EA under NDC 00378456105. Its NADAC has been published 619 times since Oct 15, 2014.

FDA first approved this application on Aug 21, 2014. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

potassium chloride
$0.0838per EA

Strength

10 meq/1

NDC

00378456105

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA204662

FDA Approved

8/21/2014

TE Code

AB2

On Market Since

11/9/2016

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 619 times since Oct 15, 2014, and over the history we have for it it has declined 70.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0838 per EA
All-time high$0.3010 (Mar 11, 2015)
All-time low$0.0838 (Aug 19, 2026)
52-week high$0.0943
52-week low$0.0838
Median price$0.1613
Average price$0.1679
Largest weekly change+35.0% (Aug 21, 2024)
Weeks tracked619
Tracking sinceOct 15, 2014

Price History

1W

-1.4%

1M

-1.4%

3M

-5.1%

6M

-7.4%

1Y

-6.0%

3Y

-33.9%

5Y

-43.0%

All

-70.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.0838 per EA (NDC 00378456105), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 70.2%. It has been tracked across 619 weekly CMS publications since Oct 15, 2014.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Oct 15, 2014, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0838 (Aug 19, 2026) to a high of $0.3010 (Mar 11, 2015), with a median of $0.1613 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as POTASSIUM CL ER 10 MEQ TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 00378456105) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.